Highlight of 2023: CAR T cells driving precision therapy for autoimmune disease

Abstract

CAR T cell therapy is showing remarkable results in autoimmune disease with treatment‐refractory patients showing durable drug‐free remission. Here, we highlight five key papers from 2023 that are driving the development of CAR T cells to improve precision, safety, efficacy and accessibility for the treatment of autoantibody‐associated autoimmune diseases.